Acute Effect of Transcutaneous Electrical Nerve Stimulation in Heart Failure
TensIC
1 other identifier
interventional
30
1 country
1
Brief Summary
The purpose of this study is to determine acute effect the transctutaneous electrical nerve stimulation in sympathetic and parassympathetic system in individuals with heart failure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2010
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2010
CompletedFirst Submitted
Initial submission to the registry
December 1, 2010
CompletedFirst Posted
Study publicly available on registry
December 3, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedAugust 2, 2012
November 1, 2010
2.3 years
December 1, 2010
August 1, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
differences in blood levels of catecholamines differences in blood levels of catecholamines differences in blood levels of catecholamines Differences in blood levels of catecholamines
For evaluation of catecholamines (epinephrine, norepinephrine and dopamine) will be held one antecubital venipuncture and collected into tubes containing ethylenediaminetetraacetic acid (EDTA).
one minute before and after transutaneous electrical nerve stimulation intervention (acute effect)
Secondary Outcomes (1)
improvement of heart rate variability
one minute before and after transcutaneous electrical nerve stimulation intervention (acute effect)
Study Arms (1)
tens
EXPERIMENTALInterventions
Application of low frequency (10-Hz) and high frequency (100-Hz) TENS, in two different days
Eligibility Criteria
You may qualify if:
- Possess stable heart failure grade II or III according to NYHA;
- Ejection fraction \<40% determined by echocardiography;
- Having no change in drug therapy one month before being included in the study;
- There have been Myocardial Infarction (AMI) three months before study entry;
You may not qualify if:
- Patients with grade IV heart failure according to NYHA;
- Acute respiratory;
- Unstable angina;
- Ventricular arrhythmia, unstable until three months before the start of the study;
- Pacemaker;
- Active smoking;
- Diabetes mellitus;
- And fever or infectious disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rodrigo Della Méa Plentz
Porto Alegre, Rio Grande do Sul, Brazil
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
December 1, 2010
First Posted
December 3, 2010
Study Start
November 1, 2010
Primary Completion
March 1, 2013
Study Completion
December 1, 2013
Last Updated
August 2, 2012
Record last verified: 2010-11